Position in GILD
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$480,470
-$94,569 QoQ
Shares Held
3,803
-7.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,387
of 2,265 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Optas, LLC holds $14,428,752 across 12 Drug Manufacturers - General names. GILD ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,980 | $4,773,731 | |
| 2 | JNJ |
Johnson & Johnson
|
9,047 | $2,297,666 | |
| 3 | ABBV |
AbbVie Inc.
|
7,513 | $1,890,569 | |
| 4 | AZN |
Astrazeneca PLC
|
6,859 | $1,300,603 | |
| 5 | MRK |
Merck & Co., Inc.
|
9,402 | $1,208,156 | |
| 6 | AMGN |
Amgen Inc
|
1,817 | $657,970 | |
| 7 | NVS |
Novartis AG
|
4,098 | $642,237 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
3,803 | $480,470 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $480,470 | 3,803 | Shares | Other | 2026-07-21 | |
| 2026-03-31 | $575,039 | 4,126 | Shares | Other | 2026-04-27 | |
| 2025-12-31 | $463,341 | 3,775 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $397,047 | 3,577 | Shares | Other | 2025-10-15 | |
| 2025-06-30 | $382,167 | 3,447 | Shares | Other | 2025-07-23 | |
| 2025-03-31 | $329,873 | 2,944 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $239,883 | 2,597 | Shares | Sole | 2025-01-24 | |
| 2020-09-30 | $219,139 | 3,468 | Shares | Other | 2020-10-23 | |
| 2020-03-31 | $292,610 | 3,914 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||